Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation (NCT03810872) | Universitair Ziekenhuis Brussel | 2017-06-21 |
Track Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.